Esketamine on Postpartum Depression in Cesarean Section Women
Status:
Not yet recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
This study was to explore the preventive effect of esketamine on postpartum depression in
cesarean section, and to evaluate the safety of the drug
Phase:
N/A
Details
Lead Sponsor:
Ailin Luo
Collaborators:
Central South University Dalian Municipal Central Hospital First Affiliated Hospital of Guangxi Medical University Guangdong Women and Children Hospital Maternal and Child Health Hospital of Hubei Province Shandong Jining No.1 People's Hospital The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School The First Affiliated Hospital of Anhui Medical University The First Affiliated Hospital of University of South China Third Affiliated Hospital of Zhengzhou University